0.9% sterile, unpreserved saline
Sponsors
Evolus, Inc.
Conditions
Glabellar Frown Lines
Phase 3
A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001
CompletedNCT02334423
Start: 2015-01-31End: 2015-12-31Updated: 2019-03-27
A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002
CompletedNCT02334436
Start: 2015-01-31End: 2015-12-31Updated: 2019-03-27